K. Nanya

Characterization of a cytotoxic factor produced by rat bladder cancer cell line: its identity to TNF alpha.

H. Hojo, Y. Hashimoto, N. Kayagaki, 1994, Immunology letters.

Application of the Plan-Do-Check-Act Cycle for Managing Immune-Related Adverse Events

S. Yuasa, S. Hibi, Yoshiteru Tanaka, 2021, Journal of Analytical Oncology.

Adaptation to the Progress in Cancer Genomic Medicine by a Japanese Community Hospital

S. Hibi, K. Ina, S. Kayukawa, 2023, Journal of Cancer Research Updates.

Early immunological responses to the mRNA SARS-CoV-2 vaccine in patients with neuromuscular disorders

A. Okumura, M. Katsuno, Ayuka Murakami, 2022, Frontiers in Immunology.

Management of Hepatitis B Virus Reactivation after the Completion of Cancer Chemotherapy using a Plan-do-Check-Act Cycle

S. Yuasa, S. Hibi, K. Ina, 2022, Journal of Cancer Research Updates.

Spike Antibody Titers Evaluation after a 2-Dose Regimen of BNT162b2 Vaccination in Healthcare Workers Previously Infected with SARS-CoV-2

Y. Ota, K. Ina, S. Hasegawa, 2021, Microbiology spectrum.